News Center

WIRB–Copernicus Group to Co-present Fifteen Sessions at Public Responsibility in Medicine and Research Conference

PRINCETON, N.J., Nov. 08, 2016 – WIRB-Copernicus Group® (WCG™), one of the world’s leading providers of solutions that measurably improve the quality and efficiency of clinical research, announced today that eight of its thought leaders are presenting during 15 sessions at the Public Responsibility in Medicine & Research (PRIM&R) Advancing Ethical Research (AER) 2016 Conference, […]

CenterWatch Joins WIRB-Copernicus Group

Kenneth A. Getz, CenterWatch founder and owner, to join WCG board of directors PRINCETON, N.J., June 22, 2016 – WIRB-Copernicus Group® (WCG™), one of the world’s leading providers of solutions that measurably improve the quality and efficiency of clinical research, today announced its acquisition of CenterWatch, the leading provider of clinical trial industry news and […]

WIRB-Copernicus Group Acquires Data and Technology from karmadata

Exclusive license agreement with market leader enriches WCG’s clinical trial activation solution, further accelerates study start-up for sponsors and CROs PRINCETON, N.J., June 15, 2016 – WIRB-Copernicus Group® (WCG™), one of the world’s leading providers of solutions that measurably improve the quality and efficiency of clinical research, today announced an industry-transforming agreement with karmadata, the […]

WCG to Co-sponsor Webinar with NYU School of Medicine’s Division of Bioethics to Commemorate 50th Anniversary of Publication of Seminal Paper on Research Ethics

PRINCETON, N.J., June 02, 2016 – WIRB-Copernicus Group® (WCG™), one of the world’s leading providers of solutions that measurably improve the quality and efficiency of clinical research, today announced that the company will partner with NYU School of Medicine’s Division of Bioethics to co-sponsor a webinar celebrating the 50th anniversary of the publication of Dr. […]

Clintrax Global Named as Finalist for Triangle Business Journal’s 2016 Life Sciences Awards

PRINCETON, N.J., May 11, 2016 – WIRB-Copernicus Group® (WCG™), one of the world’s leading providers of solutions that measurably improve the quality and efficiency of clinical research, today announced that its Clintrax Global company has been named a finalist for the Triangle Business Journal’s (TBJ’s) 2016 Life Sciences Awards. The Life Sciences Awards recognize both […]

WCG Biosafety Expert Dr. David Emery to Discuss Regulatory Changes to Gene Therapy Research Reviews at the ASGCT Annual Meeting

PRINCETON, N.J., Apr. 29, 2016 – WIRB-Copernicus Group® (WCG™), one of the world’s leading providers of solutions that measurably improve the quality and efficiency of clinical research, today announced that David Emery, PhD, its director of institutional biosafety committee (IBC) services, will present at the American Society of Gene & Cell Therapy (ASGCT) 19th Annual […]

WCG Biosafety Webinar to Discuss Implications of Regulatory Changes to Gene Therapy Research Reviews

PRINCETON, N.J., May 9, 2016 – WIRB-Copernicus Group® (WCG™), one of the world’s leading providers of solutions that measurably improve the quality and efficiency of clinical research, today announced that it will be hosting a webinar at 12 pm PT/3 pm ET on Wednesday, May 11 to discuss the new guidelines for the National Institutes […]

WCG Biosafety Expert Dr. David Emery to Discuss Regulatory Changes to Gene Therapy Research Reviews at the ASGCT Annual Meeting

PRINCETON, N.J., Apr. 29, 2016 – WIRB-Copernicus Group® (WCG™), one of the world’s leading providers of solutions that measurably improve the quality and efficiency of clinical research, today announced that David Emery, PhD, its director of institutional biosafety committee (IBC) services, will present at the American Society of Gene & Cell Therapy (ASGCT) 19th Annual […]

Alphabetical Glossary of Terms: Gene Therapy & Immunotherapy for Cancer

The purpose of this glossary is to provide clarification of the most commonly used terms related to cancer research and treatment using gene therapy and immunotherapy. The terms in this glossary are listed alphabetically, with illustrations where appropriate. Author: Daniel Kavanagh, PhD Senior Director, Biosafety and Gene Therapy WCG Biosafety

WCG Thought Leaders to Help Debunk Regulatory Myths and Discuss Proposed Changes to Human Subject Protections at MAGI Clinical Research Conference East

PRINCETON, N.J., Apr. 18, 2016 – WIRB-Copernicus Group® (WCG™), one of the world’s leading providers of solutions that measurably improve the quality and efficiency of clinical research, today announced that two of its thought leaders will be presenting at MAGI’s Clinical Research Conference – 2016 East, which is being held at the Westin Copley Place […]